Firdapse Tablet
Product Images NDC 69616-211

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Firdapse (NDC 69616-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Catalyst Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Firdapse 01)

FDA Label Image

Principal Display Panel (10 mg Tablet Blister Pack Carton)

Principal Display Panel (10 mg Tablet Blister Pack Carton)
This is a description for an Amifampridine tablet under the brand name FIRDAPSE. It comes in a bottle with 10 tablets each, and each tablet contains 10mg of Amifampridine phosphate (equivalent to 18.98mg of Amifampridine). The full prescribing details and usual dosage can be found in the package insert. It should be stored between 20°C-25°C (68°F-77°F) with occasional excursions from 15°C-30°C (59°F-86°F), in the original child-resistant package. This medicine is for oral use only and should not be dispensed without a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.